Delivery Order SPE2DB24D1007-SPE2DB25FCBAT
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,549.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Prilosec DR 10 mg suspension, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg suspension. The $4,689.52 firm fixed price contract has a completion date of July 3, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3101|SPE2DB24FRBE2) from the Defense Logistics Agency (DLA) for the supply of Prilosec DR 2.5 mg Suspension, valued at $12,325.17. The contract has a ceiling value of $12,325.17 and an ultimate completion date of February 9, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, valued at $7,577.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) designated as SPE2DX, which has a total potential value of $999,999,999.00 and provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government agencies through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.92 Firm Fixed Price Delivery Order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a medication, with a period of performance through May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,594.28 for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 31, 2024, with a completion date of February 1, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S, a pharmaceutical product, with a ceiling value of $4,235.30 and a period of performance through May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,845,873 units of 40 mg omeprazole delayed-release capsules. The contract has a ceiling value of $2,288.34 and runs through April 9, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,594,942 units of Omeprazole DR 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $2,456.24 and an ultimate completion date of April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,058.80, is for the delivery of 4,567,555,829 Omeprazole DR 20 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...